Viewing Study NCT01522768


Ignite Creation Date: 2025-12-24 @ 5:55 PM
Ignite Modification Date: 2025-12-29 @ 5:44 PM
Study NCT ID: NCT01522768
Status: COMPLETED
Last Update Posted: 2023-11-01
First Post: 2012-01-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: